SCHEMBL6813834

SCHEMBL6813834

C=C(c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C#CC(C)(C)C)=C(C)CC2(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 13/20 0.49
RARB P10826 12/20 0.49
RARG P13631 11/20 0.49
RARA P10276 9/20 0.49
RXRB P28702 5/20 0.49
RXRG P48443 4/20 0.49
CYP26A1 O43174 2/20 0.42
MEN1 O00255 1/20 0.42
ABCB11 O95342 1/20 0.42
ESR1 P03372 1/20 0.42
PGR P06401 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD1 P21728 1/20 0.42
TBXA2R P21731 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRM1 P35372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814439 0.89 RARB (0.37) RXRARARBRARGRARARXRB
SCHEMBL6813842 0.84 RARA (0.51) RXRARARBRARGRARACYP26A1
SCHEMBL6813836 0.84 RARA (0.51) RXRARARBRARGRARACYP26A1
SCHEMBL8028154 0.81 RXRA (0.59) RXRARARBRARGRARARXRB
SCHEMBL6813825 0.80 RARA (0.53) RXRARARBRARGRARARXRB
SCHEMBL6814443 0.73 PTPN1 (0.42) RXRARARBRARGRARACYP26A1
SCHEMBL6814451 0.73 PTPN1 (0.42) RXRARARBRARGRARACYP26A1
SCHEMBL8026327 0.71 RARB (0.59) RXRARARBRARGRARARXRB
SCHEMBL6816312 0.69 RARB (0.50) RXRARARBRARGRARARXRB
SCHEMBL6816318 0.69 RARB (0.50) RXRARARBRARGRARARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115687-B1 5,6-DIHYDRONAPHTHALENYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2004-05-26 EP disclosed
US-6194601-B1 USEFUL IN TREATMENT OF SKIN DISORDERS SUCH AS ACNE AND DAMAGE FROM AGE OR IRRADIATION; CHRONIC SKIN INFLAMMATORY INFLAMMATORY DISEASES SUCH AS PSORIASIS AND ATOPIC DERMATITIS; ANTITUMOR AGENTS FOR BREAST CANCER, LUNG CANCER; NONTOXIC BRISTOL-MYERS SQUIBB COMPANY 2001-02-27 US disclosed